HIPEC surgery inserts high doses of chemotherapy directly into the abdomen, where traditional methods of chemotherapy cannot effectively reach. This innovative procedure can improve long-term outcomes and provide more treatment options for patients who have been diagnosed with inoperable or advanced stage cancer.

The present review summarizes the current evidence on the therapeutic role of HIPEC in various gynaecological malignancies, indicate those cancer types and settings in which HIPEC has an evidence-based beneficial impact.

HIPEC involves the infusion of 3–6 l of a hyperthermic perfusate, composed of a crystalloid vehicle and the chemotherapy of choice, through the peritoneal cavity following optimal CRS.

Hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery has been extensively studied in patients with peritoneal carcinomatosis, and it holds promise as a therapeutic strategy in both primary and recurrent scenarios.

Hyperthermic intraperitoneal chemotherapy (HIPEC) is cancer treatment for tumors in your abdominal (peritoneal) cavity. This is the place in your belly that holds your liver, stomach and several other organs. During treatment, surgeons remove cancerous tumors.

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a type of hyperthermia therapy used in combination with surgery in the treatment of advanced abdominal cancers. [1] In this procedure, warmed anti-cancer medications are infused and circulated in the peritoneal cavity (abdomen) for a short period of time.

Hyperthermic intraperitoneal chemotherapy (HIPEC), along with optimal cytoreductive surgery, has been debated to be a viable option for the treatment of advanced epithelial ovarian cancer with peritoneal carcinomatosis. HIPEC is associated with a ...

2022年9月15日 · Ovarian cancer is the most lethal gynecologic malignancy. Although treatment with hyperthermic intraperitoneal chemotherapy (HIPEC) has shown promising results, its role remains elusive. The aim of this study was to assess the comprehensive randomized evidence for the use versus non-use of HIPEC in primary and recurrent ovarian cancer.

2020年9月1日 · Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) may be used to treat peritoneal based malignancies, such as epithelial ovarian cancer (EOC). Despite results of clinical trials supporting an increasing indication for HIPEC in EOC, concerns have existed regarding morbidity and challenges with initiating HIPEC at ...

Hyperthermic intraperitoneal chemotherapy (HIPEC) is a cancer treatment that involves filling the abdominal cavity with chemotherapy drugs that have been heated. Also known as “hot chemotherapy,” HIPEC is performed after the surgeon removes tumors or lesions from the abdominal area.